MedReleaf Corp (LEAF) Insider Sells C$910,800.00 in Stock
MedReleaf Corp (TSE:LEAF) insider Stephen Arbib sold 50,600 shares of the stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of C$18.00, for a total value of C$910,800.00.
MedReleaf Corp (TSE LEAF) traded up C$0.15 during trading on Friday, reaching C$17.55. The company’s stock had a trading volume of 310,102 shares, compared to its average volume of 1,057,422. MedReleaf Corp has a 12-month low of C$6.81 and a 12-month high of C$31.25. The company has a market cap of $1,710.00 and a price-to-earnings ratio of 856.00.
A number of brokerages have recently weighed in on LEAF. Canaccord Genuity set a C$15.00 target price on MedReleaf and gave the stock a “speculative buy” rating in a research note on Thursday, November 2nd. Eight Capital raised their price objective on MedReleaf from C$13.00 to C$20.00 and gave the stock a “buy” rating in a research note on Wednesday, November 15th. Finally, Cowen raised their price objective on MedReleaf from C$20.00 to C$36.00 in a research note on Monday, January 8th.
TRADEMARK VIOLATION NOTICE: “MedReleaf Corp (LEAF) Insider Sells C$910,800.00 in Stock” was published by Daily Political and is the property of of Daily Political. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.dailypolitical.com/2018/02/09/medreleaf-corp-leaf-insider-sells-c910800-00-in-stock.html.
MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.
Receive News & Ratings for MedReleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedReleaf and related companies with MarketBeat.com's FREE daily email newsletter.